RESEARCH PAPER
Awareness, interest, and willingness to undergo cancer genetic testing among university students: a cross-sectional survey
 
More details
Hide details
1
Master Program in Health Care Management, Faculty of Medical Sciences, AAB College, Prishtina, Kosovo
 
2
Department of Anatomical Pathology, Faculty of Medicine, University of Prishtina, Prishtina, Kosovo
 
3
Orthopedic Clinic, University Clinical Centre Kosovo, Prishtina, Kosovo
 
 
Submission date: 2026-01-26
 
 
Final revision date: 2026-02-24
 
 
Acceptance date: 2026-07-03
 
 
Online publication date: 2026-07-08
 
 
Corresponding author
Rinë Limani   

Department of Anatomical Pathology, Faculty of Medicine, University of Prishtina, Str. “George Bush” No. 31, 10 000 Prishtina, Kosovo
 
 
 
KEYWORDS
TOPICS
ABSTRACT
Background:
This study examined university students’ awareness, interest, and willingness to have cancer genetic testing to guide future prevention and implementation efforts.

Material and methods:
A cross-sectional online survey included 446 university students in Kosovo. The study assessed awareness of cancer-related genetic testing, interest in learning about actionable inherited cancer risk factors, and willingness to undergo testing. Associations with sociodemographic variables were examined using chi-square tests.

Results:
The participants showed moderate awareness of cancer genetic testing. Students at private universities were more aware than those at public universities (62.2% vs. 44.6%; p=0.001). Most students (87.7%) were interested in learning about inherited cancer risks, with women showing more interest than men (p=0.013). Willingness to be tested under ideal conditions was also high (87.5%). There were no significant links between outcomes and age, residence, income, household size, health insurance, having a family doctor, or perceived cancer risk.

Conclusions:
Although awareness was moderate, university students showed high interest and strong willingness to have hereditary cancer genetic testing, suggesting significant unmet demand. These results highlight the need for targeted education, more genetic counseling, clear referral systems, and better clinical infrastructure to include cancer genetic services in national prevention and early detection plans, with a focus on fair access.
REFERENCES (30)
1.
Tung N, Ricker C, Messersmith H, Balmaña J, Domchek S, Stoffel EM, et al. Selection of germline genetic testing panels in patients with cancer: ASCO guideline. J Clin Oncol. 2024; 42(21): 2599-2615. https://doi.org/10.1200/JCO.24....
 
2.
Turnbull C, Achatz MI, Balmaña J, Castro E, Curigliano G, Cybulski C, et al. Breast cancer germline multigene panel testing in mainstream oncology based on clinical-public health utility: ESMO Precision Oncology Working Group recommendations. Ann Oncol. 2025; 36(8): 853-865. https://doi.org/10.1016/j.anno....
 
3.
Mosele MF, Westphalen CB, Stenzinger A, Barlesi F, Bayle A, Bièche I, et al. Corrigendum to “Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group”: [Ann Oncol 35 (2024) 588-606]. Annals of Oncology. 2025; 36(4): 472. https://doi.org/10.1016/j.anno....
 
4.
Cherney B, Diaz A, Chavis C, Ghattas C, Evans D, Arambula D, et al. The next-generation sequencing quality initiative and challenges in clinical and public health laboratories. Emerg Infect Dis. 2025; 31(13): 14-17. https://doi.org/10.3201/eid311....
 
5.
Genomics England. Transforming science into healthcare, together: annual report 2022 [Internet]. London: Genomics England; 2023 [access 2026 Jan 13]. Available from: https://www.genomicsengland.co....
 
6.
FinnGen. FinnGen research project [Internet]. Helsinki: University of Helsinki [access 2026 Jan 13]. Available from: https://www.finngen.fi/en.
 
7.
Indian Cancer Genome Atlas. Mapping India’s cancer genome [Internet]. Pune, Maharashtra : ICGA Foundation [access 2026 Jan 13]. Available from: https://www.icga.in.
 
8.
Brankovic-Magic M. BRCA testing in Serbia and Montenegro. Hered Cancer Clin Pract. 2006; 4: 12.https://doi.org/10.1186/1897-4....
 
9.
Dobričić J, Krivokuća A, Brotto K, Mališić E, Radulović S, Branković-Magić M. Serbian high-risk families: BRCA mutation spectra and frequency. J Hum Genet. 2013; 58: 501-507. https://doi.org/10.1038/jhg.20....
 
10.
Cavic M, Nikolic N, Marinkovic M, Damjanovic A, Krivokuca A, Tanic M, et al. Two decades of progress in personalized medicine of colorectal cancer in Serbia—insights from the Institute for Oncology and Radiology of Serbia. Biomedicines. 2024; 12(10): 2278. https://doi.org/10.3390/biomed....
 
11.
Martinetti D, Costanzo R, Kadare S, Alimehmeti M, Colarossi C, Canzonieri V, et al. KRAS and BRAF mutations in colon cancer from Albanian patients. Diagn Pathol. 2014; 9: 187. https://doi.org/10.1186/s13000....
 
12.
Kostovska IM, Jakovchevska S, Jakimovska-Özdemir M, Kiprijanovska S, Kubelka-Sabit K, Jasar D, et al. BRCA1 c.3700_3704del frequency among Albanians from Kosovo. Rep Pract Oncol Radiother. 2022; 27(2): 303-309. https://doi.org/10.5603/RPOR.a....
 
13.
Rao ND, Fullerton SM, Shirts BH, Chen LS, Henrikson NB. Applying health equity implementation science frameworks to population genetic screening. Front Health Serv. 2024; 4: 1455365. https://doi.org/10.3389/frhs.2....
 
14.
Agrawal L, DaSouza RO, Mulgund P, Chaudhary P. The role of online support, caregiving, and gender in preventative cancer genetic testing participation: cross-sectional study from a national study. JMIR Cancer. 2025; 11: e67650. https://doi.org/10.2196/67650.
 
15.
Leerschool AR, Wesselius A, Gopalakrishna G, Zeegers MP. Acceptability, consideration, intention, and uptake of six common types of direct-to-consumer genetic tests in the Netherlands. J Genet Couns. 2025; 34(6): e70142. https://doi.org/10.1002/jgc4.7....
 
16.
Ye X, Xu T, Cao J, Li G, Zhuang M, Hu G, et al. Knowledge, attitude, and practice toward genetic testing in breast cancer patients in China. PLoS One. 2025; 20(5): e0322526. https://doi.org/10.1371/journa....
 
17.
Lee NM, VanDyke MS, Abitbol A, Wallace K, Meneses C. An analysis of direct-to-consumer genetic testing portals and their communication of health risk and test limitations. J Genet Couns. 2025; 34(2): e1967. https://doi.org/10.1002/jgc4.1....
 
18.
Conner S, Theoryn T, Dusic E, Beers F, Knerr S, Norquist B, et al. Primary care provider practices, attitudes, and confidence with hereditary cancer risk assessment and testing: a mixed methods study. Genet Med. 2025; 27(4): 101307. https://doi.org/10.1016/j.gim.....
 
19.
European Commission. Kosovo report 2023 [Internet]. Brussels: European Commission; 2023 [access 2026 Jan 13]. Available from: https://enlargement.ec.europa.....
 
20.
European Commission. Kosovo report 2024 [Internet]. Brussels: European Commission; 2024 [access 2026 Jan 13]. Available from: https://enlargement.ec.europa.....
 
21.
Kosovo Agency of Statistics. [Series 5: Social statistics. Health statistics 2024] [Internet]. Pristina: KAS; 2024 [access 2026 Jan 13]. Available from: https://askapi.rks-gov.net/Cus... (in Albanian).
 
22.
Roberts MC, Foss KS, Henderson GE, Powell SN, Saylor KW, Weck KE, et al. Public interest in population genetic screening for cancer risk. Front Genet. 2022; 13: 886640. https://doi.org/10.3389/fgene.....
 
23.
Nees J, Struewe F, Schott S. Medical students’ knowledge on cancer predisposition syndromes and attitude toward eHealth. Arch Gynecol Obstet. 2024; 309: 1535-1541. https://doi.org/10.1007/s00404....
 
24.
Hermanto I, Chandra CK, Utari A, Winarni TI, Cayami FK. Knowledge of genetics and attitudes toward genetic testing among university students in Indonesia. J Community Genet. 2024; 15: 433-447. https://doi.org/10.1007/s12687....
 
25.
Guertler D, Reinhard AK, Ulbricht S, Chenot JF, Felbor U, Wurm S. Acceptance and attitudes towards genetic cancer testing among German general practice patients: a cross-sectional survey. Fam Med Community Health. 2025; 13(3): e003395. https://doi.org/10.1136/fmch-2....
 
26.
Adejumo PO, Aniagwu TIG, Awolude OA, Adedokun B, Kochheiser M, Sowunmi A, et al. Cancer genetic services in a low- to middle-income country: cross-sectional survey assessing willingness to undergo and pay for germline genetic testing. JCO Glob Oncol. 2023; 9: e2100140. https://doi.org/10.1200/GO.21.....
 
27.
Ghanim M, Rabayaa M, Alqub M, Hanani A, Abuawad M, Rahhal B, et al. Investigating knowledge and attitudes toward genetic testing and counseling among Palestinians. Sci Rep. 2025; 15(1): 4446. https://doi.org/10.1038/s41598....
 
28.
Fahim SM, Westrick SC, Qian J, Ngorsuraches S, Watts Alexander CS, Lloyd KB, et al. A survey on awareness, knowledge and preferences toward genetic testing among the United States general public. Per Med. 2024; 21(2): 117-129. https://doi.org/10.2217/pme-20....
 
29.
Kilbride MK, Kessler LJ, Cronier B, Park JJ, Cacioppo CN, Beem J, et al. Test-takers’ perspectives on consumer genetic testing for hereditary cancer risk. Front Genet. 2024; 15: 1374602. https://doi.org/10.3389/fgene.....
 
30.
Wu Y, Sun Z, Zheng Q, Miao J, Dorn S, Mukherjee S, et al. Pervasive biases in proxy genome-wide association studies based on parental history of Alzheimer’s disease. Nat Genet. 2024; 56: 2696-2703. https://doi.org/10.1038/s41588....
 
eISSN:2354-0265
ISSN:2353-6942
Journals System - logo
Scroll to top